Tuesday, October 14, 2014 12:52:15 PM
Company Description:
Biomagnetics Diagnostics Corporation is an advanced medical device and biotechnology company. Our revolutionary diagnostics system focuses on real-time testing for the actual presence of the virus/ toxin/ disease itself, and not for antibodies produced by the body's immune system which may take anywhere from weeks to months to appear. This allows for much earlier detection and treatment, as well as delivering the test at a fraction of current costs.
The FDA is currently looking for new devices to more efficiently scan for the ebola virus, could IOBS be the new screening breakthrough?
http://www.fda.gov/medicaldevices/safety/emergencysituations/ucm161496.htm#ebola
On August 5, 2014, the FDA issued an Emergency Use Authorization (EUA) to authorize the emergency use of the U.S. Department of Defense (DoD) EZ1 Real-time RT-PCR Assay for the presumptive detection of Ebola Zaire virus (detected in the West Africa outbreak in 2014) in Trizol-inactivated whole blood or Trizol-inactivated plasma specimens from individuals in affected areas with signs and symptoms of Ebola virus infection or who are at risk for exposure or may have been exposed to the Ebola Zaire virus (detected in the West Africa outbreak in 2014) in conjunction with epidemiological risk factors. This authorization is limited to the use of the authorized EZ1 rRT-PCR Assay on specified instruments by laboratories designated by DoD.
These devices are specifically designed to be battery operated and ultraportable, allowing for the rapid detection of various viral and bacterial pathogens by relatively untrained personnel outside of the laboratory setting.
http://www.biomagneticsbmgp.com/IOBS.html
Aside from being able to quickly scan at airports and such, BMGP has a magnetic test to detect viral infections which has TWO PATENTS!
Biomagnetics Diagnostics Corp. has designed a revolutionary system of diagnostics. Our High Throughput Screening – Magnetic Testing Platform (HTS-MTP) is designed to detect both qualitative (chemical identification of the elements present in a substance) and quantitative (number of specific elements in a substance) results from a single test.
The HTS-MTP system is designed to detect the virus (not the antibodies the human body produces to react to the virus) in a fraction of the time--72 to 96 hours. All with near 100% accuracy.
http://www.biomagneticsbmgp.com/hts.html
Patent Link:
http://trove.nla.gov.au/work/83035468?q=+&versionId=96347871
Page 3 here stats they "were in negotiations with major us agency"
About there screening process and detection devices!
http://www.slideshare.net/Biomagnetics/bmgp-overview
Twitter: @RRoadRunner3
NOT INVESTMENT ADVICE, I POST PERSONAL OPINIONS ONLY! I CONDUCT THOROUGH DD AND DO MY BEST TO MAKE SURE ALL THE INFORMATION IS CORRECT. PLEASE DO YOUR OWN DD BEFORE INVESTING. I OWN SHARES IN ANY COMPANY I CONDUCT DD ON.
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM